MapLight Therapeutics, Inc. MPLT
6.65 USD +0.08 (+1.22%)
Regular-session close
6.64 -0.01 -0.15%
After hours · Nov 18, 4:19 PM ET
6.43 Day range 6.86
6.06 52-week range 40.43
- YTD
- -62.15%
- 1 year
- -55.28%
News
benzinga.com MapLight Therapeutics Q3 EPS $(0.97) Beats $(1.16) Estimate MapLight Therapeutics (NASDAQ:MPLT) reported quarterly losses of $(0.97) per share which beat the analyst consensus estimate of $(1.16) by 16.38 percent. This is a 97.39 percent increase over losses…
globenewswire.com MapLight Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update Planning underway for ZEPHYR-2, the confirmatory Phase 3 trial of ML-007C-MA in schizophrenia, with topline results expected in 2028
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers SCWorx (NASDAQ:WORX) stock rose 47.8% to $3.96 during Tuesday's pre-market session. Integra Lifesciences (NASDAQ:IART) shares increased by 31.97% to $17.75. The market value of their…
